Abstract: A chewable composition is provided. The composition includes a gelling component in a sufficient amount to provide a cohesive gelled product and not more than 1.5% w/w and an active pharmaceutical ingredient (API), wherein the chewable composition has a gel strength up to 10,000 g, measured by pressing force test.
Type:
Application
Filed:
June 9, 2022
Publication date:
May 2, 2024
Applicant:
Trima Israel Pharmaceutical Products Maabarot, Ltd.
Inventors:
Eitan KADDAR, Ran VIGDOR, Mariana SHWARTZMAN